In the paper titled “Sarcoma Immunotherapy: Past Approaches and Future Directions” in the following sentence: “Currently, there is a phase II trial of a trivalent peptide vaccine to the gangliosides GD2, GD3, and GM2 in patients with sarcoma that have had solitary metastases excised (NCT00597272),” the corrected identifier should be NCT01141491.
. 2015 Jun 9;2015:259817. doi: 10.1155/2015/259817
Corrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”
S P D'Angelo
1,2,*, W D Tap
1,2, G K Schwartz
1,2, R D Carvajal
1,2
S P D'Angelo
1Department of Medicine/Melanoma-Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
2Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA
Find articles by S P D'Angelo
W D Tap
1Department of Medicine/Melanoma-Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
2Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA
Find articles by W D Tap
G K Schwartz
1Department of Medicine/Melanoma-Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
2Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA
Find articles by G K Schwartz
R D Carvajal
1Department of Medicine/Melanoma-Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
2Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA
Find articles by R D Carvajal
1Department of Medicine/Melanoma-Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY 10065, USA
2Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA
✉
*S. P. D'Angelo: dangelos@mskcc.org
Received 2015 May 21; Accepted 2015 May 27; Issue date 2015.
Copyright © 2015 S. P. D'Angelo et al.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC4477290 PMID: 26180507
This corrects the article "Sarcoma Immunotherapy: Past Approaches and Future Directions" in volume 2014, 391967.